| 1 | RGN
|
| Regucalcin downregulation in human cancer.
|
| Ghanem NZ, Yamaguchi M.
|
| Life Sci. Mar 1;340:122448. doi: 10.1016/j.lfs.2024.122448. Epub 2024 Jan 19. 2024
|
| 2 | PSMB1, RGN, UPK1A
|
| Uroplakin 1a Interacts with Regucalcin and Proteasome Subunit Beta 1.
|
| Munipalli SB, Yenugu S.
|
| Reprod Sci. Dec;30(12):3520-3528. doi: 10.1007/s43032-023-01292-y. Epub 2023 Jul 19. 2023
|
| 3 | RGN
|
| Functional pleiotropy of calcium binding protein Regucalcin in signaling and diseases
|
| Danish M, Ahmad R.
|
| Cell Signal. Feb;102:110533. doi: 10.1016/j.cellsig.2022.110533. Epub 2022 Nov 25. 2023
|
| 4 | RGN
|
| Regucalcin promotes dormancy of prostate cancer.
|
| Sharma S, Pei X, Xing F, Wu SY, Wu K, Tyagi A, Zhao D, Deshpande R, Ruiz MG, Singh R, Lyu F, Watabe K.
|
| Oncogene. Feb;40(5):1012-1026. doi: 10.1038/s41388-020-01565-9. Epub 2020 Dec 15. 2021
|
| 5 | RGN
|
| Extracellular regucalcin suppresses colony formation and growth independent of tumor suppressor p53 in human mammary epithelial cells.
|
| Yamaguchi M, Murata T.
|
| Tissue Cell. Dec;67:101447. doi: 10.1016/j.tice.2020.101447. Epub 2020 Oct 23. 2020
|
| 6 | RGN
|
| The Emerging Role of Regucalcin as a Tumor Suppressor: Facts and Views.
|
| Vaz CV, Correia S, Cardoso HJ, Figueira MI, Marques R, Maia CJ, Socorro S.
|
| Curr Mol Med. 16(7):607-619. doi: 10.2174/1566524016666160714124550. 2016
|
| 7 | RGN
|
| Histopathological and in vivo evidence of regucalcin as a protective molecule in mammary gland carcinogenesis
|
| Marques R, Vaz CV, Maia CJ, Gomes M, Gama A, Alves G, Santos CR, Schmitt F, Socorro S.
|
| Exp Cell Res. Jan 15;330(2):325-335. doi: 10.1016/j.yexcr.2014.08.007. Epub 2014 Aug 13. 2015
|
| 8 | RGN
|
| The role of regucalcin in bone homeostasis: involvement as a novel cytokine. 2014 . PMID: .
|
| Yamaguchi M.
|
| Integr Biol (Camb). Mar;6(3):258-66. doi: 10.1039/c3ib40217g. Epub 2014 Jan 23 2014
|
| 9 | RGN
|
| Regulatory role of regucalcin in heart calcium signaling: Insight into cardiac failure (Review).
|
| Yamaguchi M.
|
| Biomed Rep. May;2(3):303-308. doi: 10.3892/br.2014.245. Epub 2014 Mar 5. 2014
|
| 10 | AGT, RGN
|
| Senescence marker protein 30 inhibits angiotensin II-induced cardiac hypertrophy and diastolic dysfunction.
|
| Misaka T, Suzuki S, Miyata M, Kobayashi A, Ishigami A, Shishido T, Saitoh S, Kubota I, Takeishi Y.
|
| Biochem Biophys Res Commun 439(1):142-7. doi: 10.1016/j.bbrc.2013.08.002. Epub 2013 Aug 9.
2013
|
| 11 | RGN
|
| Regucalcin (RGN/SMP30) alters agonist- and thapsigargin-induced cytosolic [Ca2+] transients in cells by increasing SERCA Ca(2+)ATPase levels.
|
| Lai P, Yip NC, Michelangeli F.
|
| FEBS Lett 585(14):2291-4. Epub 2011 Jun 17.
2011
|
| 12 | RGN
|
| Regucalcin is broadly expressed in male reproductive tissues and is a new androgen-target gene in mammalian testis.
|
| Laurentino SS, Correia S, Cavaco JE, Oliveira PF, Rato L, Sousa M, Barros A, Socorro S.
|
| Reproduction 142(3):447-56. Epub 2011 Jun 16.
2011
|
| 13 | RGN
|
| Regucalcin and cell regulation: role as a suppressor protein in signal transduction.
|
| Yamaguchi M.
|
| Mol Cell Biochem 353(1-2):101-37. Epub 2011 Mar 24. Review.
2011
|
| 14 | RGN
|
| Senescence marker protein 30 (SMP30) expression in eukaryotic cells: existence of multiple species and membrane localization.
|
| Arun P, Aleti V, Parikh K, Manne V, Chilukuri N.
|
| PLoS One 6(2):e16545.
2011
|
| 15 | RGN
|
| Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease.
|
| Park H, Ishigami A, Shima T, Mizuno M, Maruyama N, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K, Itoh Y, Yoshikawa T, Fukui M, Hasegawa G, Nakamura N, Ohta M, Obayashi H, Okanoue T.
|
| J Gastroenterol 45(4):426-34. Epub 2009 Nov 28.
2010
|
| 16 | RGN
|
| Decreased senescence marker protein-30 could be a factor that contributes to the worsening of glucose tolerance in normal aging.
|
| Hasegawa G.
|
| Islets 2(4):258-60.
2010
|
| 17 | RGN
|
| Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones.
|
| Maia C, Santos C, Schmitt F, Socorro S.
|
| J Cell Biochem 107(4):667-76.
2009
|
| 18 | RGN
|
| Beta-catenin regulates vitamin C biosynthesis and cell survival in murine liver.
|
| Nejak-Bowen KN, Zeng G, Tan X, Cieply B, Monga SP.
|
| J Biol Chem 284(41):28115-27. Epub 2009 Aug 18.
2009
|
| 19 | RGN
|
| Over-expression of Senescence Marker Protein-30 decreases reactive oxygen species in human hepatic carcinoma Hep G2 cells.
|
| Handa S, Maruyama N, Ishigami A.
|
| Biol Pharm Bull 32(10):1645-8.
2009
|
| 20 | RGN
|
| Senescence marker protein 30 in acute liver failure: validation of a mass spectrometry proteomics assay.
|
| Lv S, Wang JH, Liu F, Gao Y, Fei R, Du SC, Wei L.
|
| BMC Gastroenterol 8:17.
2008
|
| 21 | RGN
|
| Transcript heterogeneity of the human gene for Ca2+-binding protein regucalcin.
|
| Misawa H, Yamaguchi M.
|
| Int J Mol Med 5(3):283-7. 2000
|
| 22 | RGN
|
| Expression and structure of senescence marker protein-30 (SMP30) and its biological significance.
|
| Fujita T, Shirasawa T, Maruyama N.
|
| Mech Ageing Dev 107(3):271-80. Review. 1999
|
| 23 | RGN
|
| Isolation of cDNA clone encoding human homologue of senescence marker protein-30 (SMP30) and its location on the X chromosome.
|
| Fujita T, et al.
|
| Biochim Biophys Acta 1263 : 249-252. 1995
|